Active Ingredient: ROFLUMILAST
Proprietary Name: ROFLUMILAST
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MCG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A208236
Product Number: 002
Approval Date: Oct 19, 2023
Applicant Holder Full Name: BRECKENRIDGE PHARMACEUTICAL INC
Marketing Status:
Prescription
Patent and Exclusivity Information
